[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100375380":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":40,"responsibleParty":59,"collaborators":18,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":18,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":18,"overallStatus":43,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Genomic Prediction Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PGT-A transfer","EXPERIMENTAL","Transfer of single chromosomally normal (euploid) blastocyst after PGT-A",[13],"Procedure: Preimplantation genetic testing for aneuploidy (PGT-A)",{"label":15,"type":16,"description":17,"interventionNames":18},"Untested blastocyst transfer","NO_INTERVENTION","Transfer of single untested blastocyst based on embryo morphology criteria.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Preimplantation genetic testing for aneuploidy (PGT-A)","24-chromosome screening for aneuploidy in the preimplantation embryo (blastocyst stage)",[9],[26],"Preimplantation genetic screening (PGS)",[28],{"name":29,"affiliation":30,"role":31},"Nathan R Treff, PhD","Genomic Prediction","PRINCIPAL_INVESTIGATOR",[33,37],{"name":29,"role":34,"phone":35,"phoneExt":18,"email":36},"CONTACT","(973) 529-4223","nathan@genomicprediction.com",{"name":38,"role":34,"phone":35,"phoneExt":18,"email":39},"Diego Marin, PhD","diego@genomicprediction.com",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"IVF Florida Reproductive Associates","RECRUITING","Margate","Florida","33063","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-80.20644,26.24453,{"lat":53,"lon":52},[56],{"name":57,"role":34,"phone":58,"phoneExt":18,"email":18},"Clinial Research","9542476200",{"type":60,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100375380","preimplantation-genetic-testing-in-women-of-advanced-maternal-age-100375380",false,"NCT04167748","Preimplantation Genetic Testing in Women of Advanced Maternal Age","GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age","GETSET","Inclusion Criteria:\n\n* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start\n* Utilization of Intracytoplasmic Sperm Injection ICSI\n* Utilization of ejaculated or testicular sperm\n* Utilization of autologous or donor sperm\n* All Controlled Ovarian Hyperstimulation (COH) protocols\n\nExclusion criteria:\n\n* Patients with anovulatory Polycystic ovarian syndrome (PCOS)\n* Utilization of donor oocytes\n* Utilization of gestational carrier\n* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages\n* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers","FEMALE","35 Years","40 Years",{"count":73,"type":74},240,"ESTIMATED","INTERVENTIONAL",[77],"NA","The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.",[80],"Infertility, Female","2025-08-19",{"date":83,"type":84},"2025-08-26","ACTUAL",{"date":86,"type":84},"2021-03-05",{"date":88,"type":74},"2026-12",{"name":5,"class":6},1]